Skip to content

Effect of butorphanol vs fentanyl on gastrointestinal function and prognosis in ICU patients

Effect of butorphanol vs fentanyl on gastrointestinal function and prognosis in ICU patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045461
Enrollment
Unknown
Registered
2021-04-15
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal function

Interventions

butorphanol group:Use butorphanol for analgesia
fentanyl group:Use fentanyl for analgesia

Sponsors

The First Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Non-abdominal surgery patients requiring mechanical ventilation and ICU monitoring after surgery. 2.Aged > 18 and <= 80 years, no gender limitation; 3.The expected treatment time in ICU is less than 48h; 4.Voluntarily sign the informed consent and participate in the study.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to opioids; 2. Patients with gastrointestinal ischemia and other diseases; 3. People with mental illness; 4. Long-term use of opioids in the past for more than 2 weeks (oral or intravenous, analgesic patch), drug addiction; 5. Liver and kidney dysfunction (liver enzymes greater than 3 times the normal value or child score above B grade; creatinine clearance rate < 50ml/min); 6. Patients with bradycardia (heart rate <= 50 beats/min), third degree atrioventricular block, systolic blood pressure <= 90 mmHg; 7. Pregnant or lactating women; 8. Patients with persistent epilepsy; 9. Patients with severe gastrointestinal dysfunction; 10. Patients who are expected to die within 48 hours; 11. Participate in other clinical trials within 30 days before enrollment; 12. The investigator believes that it is not suitable to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
Gastrointestinal function recovery;

Secondary

MeasureTime frame
analgesic effect;

Countries

China

Contacts

Public ContactChen Minying

Department of Surgical Intensive Care Unit, The First Affiliated Hospital of Sun Yat-Sen University

chenminy@mail.sysu.edu.cn+86 20 87755766 8454

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026